Our Clinical Research Services
ESTERN Medical provides global clinical research services to the Biotechnology, Pharmaceutical and
Medical Device industries across Latin America.
Clinical Research Development & Regulatory Services
Better than any other Contract Research Organization development resource, ESTERN Medical faces and
answers over Clinical R&D and Regulatory risks with our broad knowledge solutions.
These solutions are delivered by a highly responsive team of professionals building a customized
package of services based on your needs with our broad expertise and knowledge in Latin America. ESTERN
Medical serves in the local Latin American markets such as Mexico, Colombia, Venezuela, Brazil, Ecuador,
Peru, Chile, and Argentina.
From early clinical development and regulatory through late-phase clinical trials, ESTERN Medical
offers the entire range of integrated product development services you need. No matter where your point of
entry is into our resources, ESTERN Medical will craft a customized clinical and regulatory program
providing seamless access to our full range of development services to meet your specific needs in Latin
America.
With ESTERN Medical, you can minimize your risk, optimize development, and give your team every
possible advantage in accessing new insights and solutions. You can off-load tasks while uploading knowledge
assets and expertise.
At ESTERN Medical it's all about Results and Excellence
Our Expertise Phases I, II, III & IV in Latin America
ESTERN Medical is your development Contract Research Organization partner through these critical
phases.
ESTERN Medical helps you develop strategies to:
- Speed up development.
- Recruit the right patients more quickly into our key medical centers partnership and strategic
database for best results in your clinical trial success.
Strategically control costs.
- Ensure regulatory compliance many Latin American countries.
- Anticipate and remove roadblocks across each country.
Your ESTERN Medical team provides:
- Superior Project Management
With a commitment to quality, our professional consulting team ensures that your needs are met. You
have a consistent, dependable point of contact that gives you access to the entire range of ESTERN Medical
capabilities. Your team ensures that the right tools are used in order to move you efficiently through
Phases I, II, III and IV and beyond.
- Tools for Improving Study Start-Up
With a powerful mix of patient recruitment and site management tools, ESTERN Medical vastly improves
one of the most time-sensitive stages of any Phase I, II, III and IV studies.
Phase I
ESTERN Medical Phase I services brings together an unequalled breadth and depth of experience and
services. We offer unrivaled expertise for safe, innovative, early-phase human drug development to Good
Clinical Practice and Good Laboratory Practice standards.
All ESTERN Medical Phase I units combine superb healthcare and analytical facilities with the complex
amenities needed to attract, house and motivate volunteers.
The specialized staff at each site includes physicians, pharmaceutical scientists, nurses,
investigators, analysts and pharmacokineticists with experience in numerous therapeutic areas.
Each unit has established its own reputation for excellence and its own loyal client base.
ESTERN Medical is an expert in the conduct of complex, procedurally intensive Phase I studies, ESTERN
Medical provides customized services to advance your product to the next development phase. Our capacity to
accommodate large trials combined with our dedicated, experienced staff deliver effective integrated
planning and implementation for Phase I trials in Latin America.
Phase II & III Clinical Trials:
Our comprehensive Phase II-III experience, support systems and global infrastructure provide the
highest level of professional program management and services to advance your product through development
and approval.
If the blockbuster potential pharmaceutical drug is there, no one can bring it out as effectively as
ESTERN Medical; Phase II and III trials are at the heart of our business, and form the focus of the most
valuable services we offer customers. That’s because we can bring in the heavy hitters across the board – in
every medical, business and technological specialty required to manage every detail of a complex and
fast-moving project.
Phase IV
Our strength in late stage drug development derives from strategically aligning clinical research and
marketing objectives. ESTERN Medical’s post-approval group explores and implements a wide range of
strategies to capitalize on the strengths of your product and maximize its life cycle.
Safety continues to be a key issue for both physicians and patients. More than ever before,
scientists, researchers and Biotech, Pharmaceutical & Medical Device companies like yours recognize that
expanding safety initiatives is not simply an option, but a necessity. Your continued success is dependent
upon developing therapies that have a strong track record when it comes to patient safety.
ESTERN Medical understands your commitment to patient safety and offers our Safety Solution Center.
We will work with you to expand safety initiatives and will help you anticipate, and prepare for critical
issues that may arise in your development.
The Guiding Principles in the Regulatory Affairs Steps for Latin America.
At ESTERN Medical, our regulatory and safety guidance oversight services are a seamless part of the
drug development process from beginning to end.
Our regulatory have broad track record experience and a rapport with many Latin American regulatory
agency divisions, that let us explore options with customers to succeed shortest route of their clinical
trials and timeframe to bring their products to market.
It’s about having experience with the Latin American, FDA and the European regulatory authorities, so
we can explore with you the most efficient route and shortest timeframe to market. It’s therapeutic area
expertise. It’s understanding regulations, such as Common Technical Document (CTD) requirements or the
European Clinical Trial Directive.
We know what issues are likely to come up and can develop strategies to address them early on. In
addition, our knowledge of local market requirements throughout Latin American countries and specific
regions in Latin America gives you the advantage of submitting registration applications simultaneously in
any regions that interest you.
We begin with a strategic regulatory, scientific, and safety planning in the clinical trial phase
that you will be launching. And collaborate in the designing a study that integrates a full understanding of
the current regulations and the regulatory environment from the start to completion of your study, we can
help you ensure that the complete drug development process will run more smoothly and efficiently.
ESTERN Medical also provides Business Science coordination and of clinical and post-marketing studies
throughout Latin America.
IRB’s Independent Institutional Review Board in Latin America
ESTERN Medical provides you with guidance over independent ethical review of your drug and/or device
trials when review of protocols for the protection of human research subjects by an on-site board is not
available across Latin America.
Independent IRB across Latin America has provided this service to a growing national clientele of
investigators and sponsors.
ESTERN Medical IRB guidance provides independent ethical review of your drug and/or device trials
when review of protocols for the protection of human research.
The Independent IRB operates in compliance with federal regulations governing Institutional Review
Boards set forth in 21 CFR Part 56, federal regulations governing informed consent set forth in 21 CFR Part
50, as well as ICH guidelines for good clinical practices. The Independent IRB can review studies for a
single investigator or serve as a central IRB for multi-center trials across Latin America.
Confidentiality
The confidentiality of information contained in the documents submitted to the Independent IRB is
carefully preserved. Protocols, investigator drug brochures, informed consent documents, IND’s, NDA’s, PMA’s
IDE’s 510K’s safety reports, and other records are safeguarded in locked files, with access strictly limited
to the IRB staff. In addition, each Board member signs an agreement to treat all reviewed material as
confidential.
The overriding objective is to ensure that the privacy of individuals, industries and institutions
involved in the protocol is respected.
Meeting Schedule
The IRB meetings are usually twice a month during the year. Specific meeting dates can be provided
upon request. In addition to the schedule above, ad hoc sessions are convened to meet a client's special
needs.
Turn-Around Time
The protocol, IDB, informed consent, and any proposed advertising should be submitted to the IRB no
later than one week before the next scheduled IRB meeting. After review by the board, the investigator
and/or sponsor will be notified of the outcome within 24 hours. Expedited reviews are handled within 24-48
hours.
Quick IRB Review
The IRB meets twice a month or special meetings can be arranged. Approval letter for full-board
review items are sent approximately 48-72 hours after the IRB meeting, and expedited review items are sent
approximately 24-48 hours from their submission.
Latin America Patient Recruitment
Latin America Clinical Trials Recruitment
ESTERN Medical significantly impacts the drug development timeline by accelerating the process of
recruiting and enrolling patients into clinical trials in Latin America.
ESTERN Medical attributes its recruitment success story in recruitment due to the broad variety of
novel diseases and age-related chronic diseases, with patients largely unexposed to previous treatments and
a wide population: 552,296,094 people across 20 countries Latin America.
Therefore one of our main objectives is to keep trials on schedule - or even ahead of schedule.
ESTERN Medical is increasingly leveraging its reach and knowledge in Latin America. More and more
customers are discovering the advantages of conducting trials in the diverse non-traditional regions of the
world, where patient populations, well-trained investigators and high-quality communications systems are
readily available - and where ESTERN Medical has years of experience and expertise mastering local disease
profiles, customs and regulations. By putting it all together, we deliver speedy study start-up consulting
and top quality results that meet FDA and ICH GCP standards.
Expanded reach, easier access to specific diverse patient populations in Latin America Different
therapeutic indications tend to cluster in different regions of the world. ESTERN Medical consulting and
teams work in non-traditional regions and include physician specialists in key therapeutic areas to help
fine-tune study designs and protocols.
Patients in non-traditional regions such as Latin America have a high rate of protocol compliance and
low dropout rates because of the high standards of medical care available through clinical trials.
This and the combination of our reach and local knowledge in Latin America can result in speedy
recruitment of specific patient populations.
ESTERN Medical Patient Recruitment Data Base in Latin America
Patients Recruitment
ESTERN Medical significantly impacts the drug development timeline by accelerating the process of
recruiting and enrolling patients into clinical trials across our Latin America Medical Centers in which we
have a partnership and track record of success in diverse clinical trials phases. ESTERN Medical has the
solutions to help and guide you over our state of the art recruitment database.
ESTERN Medical database provides Biotech, Pharmaceutical and Medical Device Companies patient
enrollment solutions for clinical trials.
ESTERN Medical offers customized single-source, full-service solutions that leverage the most
cost-efficient and effective outreach, screening, and clinical site support methods for each individual
trial.
Broaden the pool of high-quality, pre-screened patients.
Accelerate the patient recruitment process.
Increase the throughput of patients during the enrollment process.
Our Patient Recruitment Solutions for Sponsors
The primary reasons clinical trials fall behind are:
Patients are unaware of study opportunities.
It is difficult to motivate patients to switch from an already-existing therapy.
Competing protocols mean there are only a limited number of patients available to
participate in studies.
There is poor planning regarding study start-up.
By accessing ESTERN Medical data base expertise and combining services on recruitment
and informatics data, sponsors can ensure success.
Patient Recruitment
ESTERN Medical employs the print and broadcast media to reach a diverse population.
ESTERN Medical produces the recruitment messages and manages media planning, placement, and
monitoring for TV and radio for clinical trials in Latin America.
Sponsors can provide a dramatic reduction in recruitment timelines by combining our broadcast-based
recruitment with our call center services.
Patient Recruitment Solutions for Investigators
ESTERN Medical recognizes the importance of the clinical investigator in the patient recruitment
process. We offer customized consulting services to help investigators streamline the patient recruitment,
screening, and enrollment process.